Skip to main content
. 2022 Dec 29;20(1):621. doi: 10.3390/ijerph20010621
ART Anti-Retroviral Therapy
aHR Adjusted Hazard Ratio
aIRR Adjusted incidence rate ratio
CENTRAL Cochrane Center for Clinical Trial
CI Confidence Interval
IPT Isoniazid Preventive Therapy
HAART Highly active antiretroviral therapy
HR Hazard Ratio
HIV Human Immune Virus
IR Incidence ratio
PLWHIV People Living with Human Immunodeficiency Virus
PY Person per Year
SD Standard Deviation
TB Tuberculosis
TST Tuberculin Skin Test
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
WHO World Health Organization